EE436 Real World Healthcare Resource Utilization (HRU) and Costs Associated With Mantle Cell Lymphoma (MCL) Therapies in the Frontline (1L) and Relapsed/Refractory (R/R) Setting
Abstract
Authors
Nilanjan Ghosh Dureshahwar Jawaid Nnadozie Emechebe Beenish S. Manzoor Mazyar Shadman